NATALIZUMAB for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 2,749 adverse event reports in the FDA FAERS database where NATALIZUMAB was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for NATALIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Multiple sclerosis relapse | 6,478 | 10.1% | 96 | 3,253 |
| Fatigue | 4,456 | 6.9% | 22 | 690 |
| Multiple sclerosis | 4,078 | 6.3% | 197 | 1,117 |
| Memory impairment | 3,024 | 4.7% | 5 | 426 |
| Malaise | 2,523 | 3.9% | 30 | 461 |
| Fall | 2,481 | 3.9% | 51 | 1,330 |
| Headache | 2,476 | 3.9% | 14 | 530 |
| Gait disturbance | 2,427 | 3.8% | 13 | 696 |
| Prescribed underdose | 2,162 | 3.4% | 56 | 545 |
| Maternal exposure during pregnancy | 1,948 | 3.0% | 6 | 357 |
| Asthenia | 1,945 | 3.0% | 36 | 658 |
| Pain | 1,911 | 3.0% | 15 | 540 |
| Urinary tract infection | 1,894 | 2.9% | 85 | 1,072 |
| Drug ineffective | 1,757 | 2.7% | 28 | 350 |
| Progressive multifocal leukoencephalopathy | 1,668 | 2.6% | 279 | 1,201 |
Other Indications for NATALIZUMAB
Multiple sclerosis (56,733)
Product used for unknown indication (3,472)
Maternal exposure timing unspecified (492)
Crohn's disease (281)
Relapsing multiple sclerosis (140)
Secondary progressive multiple sclerosis (115)
Primary progressive multiple sclerosis (27)
Paternal exposure timing unspecified (26)
Exposure via partner (24)
Disease risk factor (23)
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)
TECFIDERA (806)